Related Experiment Video

Updated: May 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Effects of HIV Medication Complexity and Depression on Adherence to HIV Medication

Virender Kumar1, William Encinosa

  • 11 Westat, Rockville, Maryland, USA 2 Agency for Healthcare Research and Quality, Rockville, Maryland, USA.

The Patient
|January 26, 2012
PubMed

Insights

Patient depression impacts adherence to highly active antiretroviral therapy (HAART) regimens. Those with high depression adhere better to complex HAART regimens, while those with low depression adhere better to simpler regimens.

Area of Science:

  • Medical adherence research
  • Psychiatric comorbidity in infectious diseases
  • HIV/AIDS treatment optimization

Background:

  • Medication adherence is crucial for effective treatment, particularly for complex regimens like highly active antiretroviral therapy (HAART).
  • The influence of patient mental health, specifically depression, on the relationship between HAART regimen complexity and adherence remains underexplored.

Purpose of the Study:

  • To investigate how mental health status modifies the association between the complexity of highly active antiretroviral therapy (HAART) regimens and patient adherence.
  • To determine if the relationship between HAART regimen complexity and adherence differs based on levels of depressive and anxiety symptoms.

Main Methods:

  • Analysis of 1192 respondents from the HIV Cost and Services Utilization Survey (HCSUS) on HAART.
  • Utilized self-reported past-week HAART adherence, current mental health status, and a regimen complexity measure.
  • Employed regression models with interaction terms to assess the differential impact of mental health and medication complexity on adherence.

Main Results:

  • Patients with high depressive/anxiety symptoms showed lower odds of HAART adherence at mean medication complexity (OR=0.78).
  • The association between adherence and regimen complexity varied significantly by mental health status.
  • Individuals with high depressive symptoms had increased odds of adherence with more complex regimens, while those with low depressive symptoms had decreased odds of adherence with increasing complexity.

Conclusions:

  • While poorer mental health is generally linked to lower adherence, individuals with high depressive symptoms may benefit from adherence support as regimen complexity increases.
  • Healthcare providers should consider tailoring adherence interventions based on both patient mental health status and the complexity of their HIV medication regimens.
Abstract

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...